Strategy for automated metabolic profiling of glioma subtypes from ex-vivo HRMAS spectra

ConclusionClassifying metabolomic profiles for new and recurrent glioma without prior assumptions regarding spectral components identified candidate in vivo biomarkers for use in assessing changes that are likely to impact treatment decisions.
Source: Metabolomics - Category: Biology Source Type: research